https://rmcalliance.org/news-updates/ 2026-07-01T23:24:31+00:00 https://rmcalliance.org/the-combination-of-bevacizumab-plus-erlotinib-is-a-new-therapeutic-option-for-rmc/ 2021-09-10T04:57:21+00:00 https://rmcalliance.org/wp-content/uploads/2021/09/cancers-13-02170-g001.png https://rmcalliance.org/wp-content/uploads/2021/09/cancers-13-02170-g001.png https://rmcalliance.org/interview-with-a-renal-medullary-carcinoma-survivor/ 2021-11-05T13:52:02+00:00 https://rmcalliance.org/wp-content/uploads/2021/09/2021-09-09_23-01-47.jpg https://rmcalliance.org/a-man-saw-blood-in-his-urine-this-is-what-happened-to-his-kidney/ 2021-11-05T14:09:14+00:00 https://rmcalliance.org/wp-content/uploads/2021/09/2021-09-09_22-58-39.jpg https://rmcalliance.org/an-athlete-squatted-500-reps-in-20-minutes-this-is-what-happened-to-his-kidneys/ 2021-11-05T14:11:50+00:00 https://rmcalliance.org/wp-content/uploads/2021/09/2021-09-09_22-54-00.jpg https://rmcalliance.org/association-of-high-intensity-exercise-with-renal-medullary-carcinoma-in-individuals-with-sickle-cell-trait/ 2022-01-14T00:00:43+00:00 https://rmcalliance.org/wp-content/uploads/2022/01/2022-01-13_17-46-32.jpg https://rmcalliance.org/new-study-investigates-germline-and-somatic-alterations-in-renal-medullary-carcinoma/ 2022-01-15T17:45:45+00:00 https://rmcalliance.org/wp-content/uploads/2021/09/2021-09-09_23-40-20.jpg https://rmcalliance.org/wp-content/uploads/2021/09/2021-09-09_23-40-20-1.jpg https://rmcalliance.org/new-study-identifies-genomic-and-immune-hallmarks-of-renal-medullary-carcinoma/ 2022-01-15T17:45:54+00:00 https://rmcalliance.org/wp-content/uploads/2021/09/1-s2.0-S1535610820301641-fx1_lrg.jpg https://rmcalliance.org/wp-content/uploads/2021/09/1-s2.0-S1535610820301641-fx1_lrg-1.jpg https://rmcalliance.org/molecular-characterization-of-the-tumor-microenvironment-in-renal-medullary-carcinoma/ 2022-07-29T00:43:29+00:00 https://rmcalliance.org/wp-content/uploads/2022/07/2022-07-28_19-37-41.jpg https://rmcalliance.org/renal-medullary-carcinomas-harbor-a-distinct-methylation-phenotype/ 2023-03-28T22:09:12+00:00 https://rmcalliance.org/renal-medullary-carcinoma-associated-with-germline-nf2-mutation/ 2023-03-28T22:17:32+00:00 https://rmcalliance.org/clinical-trial-shows-that-patients-with-rmc-rapidly-progress-following-immunotherapy-with-pembrolizumab/ 2023-07-27T20:29:24+00:00 https://rmcalliance.org/clinical-trial-shows-that-bevacizumab-does-not-add-benefit-in-renal-medullar-carcinoma/ 2023-08-08T00:04:22+00:00 https://rmcalliance.org/w-kimryn-rathmell-to-be-appointed-director-of-the-national-cancer-institute/ 2023-11-22T21:02:41+00:00 https://rmcalliance.org/radiation-therapy-in-combination-with-chemotherapy-for-patients-with-rmc/ 2024-07-09T19:20:27+00:00 https://rmcalliance.org/serum-ca-125-as-a-biomarker-in-renal-medullary-carcinoma/ 2025-02-23T22:08:29+00:00 https://rmcalliance.org/machine-learning-radiomics-to-differentiate-rmc-from-clear-cell-rcc/ 2026-04-05T17:03:33+00:00 https://rmcalliance.org/sickle-cell-disease-weakens-anti-tumor-immunity-through-cd8-t-cell-ferroptosis/ 2026-04-05T17:06:01+00:00 https://rmcalliance.org/contemporary-outcomes-of-rmc-from-the-pediatric-surgical-oncology-research-collaborative/ 2026-04-05T17:12:44+00:00 https://rmcalliance.org/smart-trial-sacituzumab-govitecan-%c2%b1-atezolizumab-opens-rmc-arm-at-nci/ 2026-04-05T17:15:59+00:00 https://rmcalliance.org/egfr-not-vegf-drives-the-response-to-bevacizumab-erlotinib-in-rmc/ 2026-04-05T17:18:08+00:00 https://rmcalliance.org/prospective-evidence-links-vigorous-physical-activity-to-rmc-risk/ 2026-04-05T17:19:48+00:00 https://rmcalliance.org/first-reported-case-of-rmc-diagnosed-during-pregnancy-chemotherapy-delivered-with-healthy-birth-outcome/ 2026-04-05T17:21:35+00:00 https://rmcalliance.org/integrated-molecular-profiling-identifies-trop2-and-other-therapeutic-targets-in-rmc/ 2026-04-05T17:24:12+00:00 https://rmcalliance.org/nivolumab-plus-ipilimumab-causes-hyperprogression-in-rmc-phase-ii-trial-results-and-potential-mechanism/ 2026-04-05T17:26:14+00:00 https://rmcalliance.org/editorial-toward-precision-therapies-for-rmc-based-on-biological-hallmarks/ 2026-04-05T17:29:29+00:00 https://rmcalliance.org/glial-transdifferentiation-in-an-rmc-brain-metastasis-after-ezh2-inhibitor-therapy/ 2026-04-05T17:32:08+00:00 https://rmcalliance.org/phase-ii-basket-trial-confirms-rmc-does-not-respond-to-the-ezh2-inhibitor-tazemetostat/ 2026-04-05T17:34:42+00:00 https://rmcalliance.org/phase-ii-trial-of-ixazomib-plus-gemcitabine-and-doxorubicin-in-rmc/ 2026-04-21T05:33:47+00:00 https://rmcalliance.org/fdg-pet-ct-improves-staging-and-treatment-management-in-rmc/ 2026-06-18T19:54:27+00:00 https://rmcalliance.org/wp-content/uploads/2026/06/Figure-2.jpg https://rmcalliance.org/panitumumab-based-egfr-blockade-in-smarcb1-deficient-rmc/ 2026-06-18T21:33:07+00:00 https://rmcalliance.org/new-rmc-trial-now-open-at-md-anderson-starmc-nct07438626/ 2026-07-01T23:24:31+00:00 https://rmcalliance.org/wp-content/uploads/2026/07/Study-schema-for-social-media.jpg